Subscribe To
Why heron therapeutics stock is getting hammered today
The biotech's Q4 results didn't live up to expectations....
March 1, 2022, 3:38 pm
Dynavax technologies: full speed ahead
Today, we 'circle back' on Dynavax Technologies, a biotech concern that just delivered solid fourth qua...
March 1, 2022, 12:12 pm
Dynavax technologies: full speed ahead
Today, we 'circle back' on Dynavax Technologies, a biotech concern that just delivered solid fourth qua...
March 1, 2022, 12:12 pm
Dynavax technologies: full speed ahead
Today, we 'circle back' on Dynavax Technologies, a biotech concern that just delivered solid fourth qua...
March 1, 2022, 12:12 pm
After plunging 26.6% in 4 weeks, here's why the trend might reverse for vir biotechnology, inc. (vir)
Vir Biotechnology, Inc. (VIR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combin...
March 1, 2022, 11:30 am
After plunging 26.6% in 4 weeks, here's why the trend might reverse for vir biotechnology, inc. (vir)
Vir Biotechnology, Inc. (VIR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combin...
March 1, 2022, 11:30 am
After plunging 26.6% in 4 weeks, here's why the trend might reverse for vir biotechnology, inc. (vir)
Vir Biotechnology, Inc. (VIR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combin...
March 1, 2022, 11:30 am
Enveric biosciences files portfolio of patent applications for tryptamine derivatives
Enveric Biosciences (NASDAQ:ENVB) announced that it has filed its tenth Patent Cooperation Treaty (PCT) application directed to tryptamine-based deriv...
March 1, 2022, 9:12 am
Enveric biosciences files portfolio of patent applications for tryptamine derivatives
Enveric Biosciences (NASDAQ:ENVB) announced that it has filed its tenth Patent Cooperation Treaty (PCT) application directed to tryptamine-based deriv...
March 1, 2022, 9:12 am
Enveric biosciences files portfolio of patent applications for tryptamine derivatives
Enveric Biosciences (NASDAQ:ENVB) announced that it has filed its tenth Patent Cooperation Treaty (PCT) application directed to tryptamine-based deriv...
March 1, 2022, 9:12 am
Should you invest in the spdr s&p biotech etf (xbi)?
Sector ETF report for XBI...
March 1, 2022, 7:39 am
Should you invest in the spdr s&p biotech etf (xbi)?
Sector ETF report for XBI...
March 1, 2022, 7:39 am
Should you invest in the spdr s&p biotech etf (xbi)?
Sector ETF report for XBI...
March 1, 2022, 7:39 am
Cortexyme: a biotech worth a look based on potential alzheimer's treatment
COR588 is the second-generation lysine gingipain inhibitor which is being developed to treat Alzheimer's Disease and other P. gingivalis diseases....
February 28, 2022, 9:15 pm
Cortexyme: a biotech worth a look based on potential alzheimer's treatment
COR588 is the second-generation lysine gingipain inhibitor which is being developed to treat Alzheimer's Disease and other P. gingivalis diseases....
February 28, 2022, 9:15 pm
Cortexyme: a biotech worth a look based on potential alzheimer's treatment
COR588 is the second-generation lysine gingipain inhibitor which is being developed to treat Alzheimer's Disease and other P. gingivalis diseases....
February 28, 2022, 9:15 pm
Schrödinger to present at truist securities life sciences ai symposium - biotech & tools
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at Truist Securities Life Sciences AI Symposium - ...
February 28, 2022, 4:30 pm
Schrödinger to present at truist securities life sciences ai symposium - biotech & tools
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at Truist Securities Life Sciences AI Symposium - ...
February 28, 2022, 4:30 pm
Schrödinger to present at truist securities life sciences ai symposium - biotech & tools
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at Truist Securities Life Sciences AI Symposium - ...
February 28, 2022, 4:30 pm
Sbio is a good place to be for biotech innovation
While biotechnology stocks and exchange traded funds continue frustrating market participants in the early innings of 2022, investors should not lose ...
February 28, 2022, 4:22 pm